Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGCA
1401
DELISTED
NextGen Acquisition Corp. II Class A Ordinary Shares
NGCA
| $18.2M | 0.01% |
1,839,074
+971,704
| +112% | +$9.62M |
|
1402
CALL
Air Products & Chemicals
APD
$67.7B
| $18.2M | 0.01% |
71,100
+41,400
| +139% | +$11.5M |
|
1403
GE Aerospace
GE
$363B
| $18.2M | 0.01% |
283,646
+1,875
| +0.7% | +$121K |
|
|
EXEEW
1404
CALL
DELISTED
Expand Energy Corp Class A Warrants
EXEEW
| $18.2M | 0.01% |
499,100
+415,660
| +498% | +$12.9M |
|
|
EXEEZ
1405
CALL
DELISTED
Expand Energy Corp Class B Warrants
EXEEZ
| $18.1M | 0.01% |
555,400
+462,685
| +499% | +$12.5M |
|
1406
CALL
Best Buy
BBY
$18B
| $18.1M | 0.01% |
171,100
+166,900
| +3,974% | +$18.7M |
|
1407
StoneCo
STNE
$2.26B
| $18.1M | 0.01% |
520,788
+318,997
| +158% | +$16.6M |
|
|
SOVO
1408
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $18.1M | 0.01% |
+1,296,116
| New | +$17.5M |
|
|
DISCK
1409
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $18.1M | 0.01% |
743,894
-919,987
| -55% | -$24.6M |
|
1410
PUT
Old Dominion Freight Line
ODFL
$41.1B
| $18M | 0.01% |
126,200
+49,600
| +65% | +$6.88M |
|
1411
Boston Beer
SAM
$1.95B
| $18M | 0.01% |
35,339
+31,658
| +860% | +$21.5M |
|
|
HIBB
1412
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $18M | 0.01% |
254,322
+59,468
| +31% | +$5.19M |
|
1413
Newmont
NEM
$142B
| $18M | 0.01% |
330,848
-276,284
| -46% | -$16.3M |
|
1414
PTC
PTC
$16.4B
| $17.9M | 0.01% |
149,737
-149,175
| -50% | -$19.9M |
|
1415
Chewy
CHWY
$10.1B
| $17.9M | 0.01% |
262,964
-185,005
| -41% | -$15.3M |
|
|
CHPM
1416
DELISTED
CHP Merger Corp. Class A Common Stock
CHPM
| $17.9M | 0.01% |
1,786,047
+151,340
| +9% | +$1.51M |
|
1417
Cognex
CGNX
$10.1B
| $17.9M | 0.01% |
222,593
-66,150
| -23% | -$5.69M |
|
1418
Xylem
XYL
$26.3B
| $17.8M | 0.01% |
144,199
-91,038
| -39% | -$11.7M |
|
1419
Texas Roadhouse
TXRH
$13.3B
| $17.8M | 0.01% |
194,979
-153,940
| -44% | -$14.4M |
|
|
ACQR
1420
DELISTED
Independence Holdings Corp. Class A Ordinary Share
ACQR
| $17.8M | 0.01% |
1,818,566
+795,605
| +78% | +$7.75M |
|
1421
Bioventus
BVS
$962M
| $17.8M | 0.01% |
1,253,937
-202,097
| -14% | -$3.11M |
|
1422
Brookfield Infrastructure
BIPC
$4.87B
| $17.7M | 0.01% |
443,778
+438,331
| +8,047% | +$19.2M |
|
1423
Patterson-UTI
PTEN
$4.39B
| $17.7M | 0.01% |
1,965,901
+1,750,410
| +812% | +$14.2M |
|
1424
CALL
HCA Healthcare
HCA
$92.8B
| $17.6M | 0.01% |
72,600
+52,600
| +263% | +$12.9M |
|
|
RPT
1425
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $17.6M | 0.01% |
1,379,515
+133,410
| +11% | +$1.7M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.